• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[降钙素原、内毒素及常见炎症标志物联合终末期肝病模型评分在慢性重型肝炎患者中的预后价值]

[Prognostic value of procalcitonin, endotoxin and common inflammatory markers combining MELD score in patients with chronic severe hepatitis].

作者信息

Zhou Qing, Tan Deming, Yi Zhaoquan, Zheng Yixiang, Lu Menghou

机构信息

Department of Infectious Diseases, Zhuzhou Central Hospital, Zhuzhou Hunan,China.

出版信息

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Apr;38(4):388-94. doi: 10.3969/j.issn.1672-7347.2013.04.009.

DOI:10.3969/j.issn.1672-7347.2013.04.009
PMID:23645239
Abstract

OBJECTIVE

To evaluate the mid-term prognostic value of procalcitonin (PCT), endotoxin and common inflammatory markers combining the model for end-stage liver disease (MELD) score in patients with chronic severe hepatitis.

METHODS

A total of 124 chronic severe hepatitis patients were enrolled, who were hospitalized in the Department of Infectious Diseases, Xiangya Hospital, Central South University from May 2011 to December 2011. Indexes of inflammation, liver and kidney function tests and MELD were determined within 24 h after the admission, and blood samples were collected for measurement of endotoxin , procalcitonin (PCT), and C-reactin protein (CRP). The outcome was confirmed after discharge follow-up at the end of the 3rd month. According to the outcome, the 124 patients were divided into a survival group (n=58) and a death group(n=66).

RESULTS

  1. Of the 124 patients, 66 died and 58 survived, with statistical difference in age, MELD score, white blood cell (WBC), polymorphonuclear (PMN), CRP and PCT by single factor analysis between the 2 groups(P<0.05). Binary logistic regression analysis indicated that age, MELD scores and PCT were highly correlated with the outcome (OR=1.07, 1.42 and 1.02 respectively, P<0.05), which could be used to predict the 3 month mid-term mortality of chronic severe hepatitis. 2)There was significant correlation between the MELD scores and the mid-term mortality. Age was positively correlated with the MELD score, and Pearson's correlation coefficient was 0.21 (P<0.05). PCT was also positively correlated with the MELD, and Spearman's correlation coefficient was 0.54 (P<0.01). 3)According to the receiver operation characteristic (ROC) curve analysis , the area under the curve (AUC) of MELD score and PCT were 0.91 and 0.77 respectively, higher than those of other indexes (P<0.01). When the MELD score was up to 30.09 or higher, the predicted mortality risk among these tested patients was the highest(82.26%). The mortality risk predicted by PCT combining MELD score and PCT alone was lower than by MELD score alone (75.00%), but the specificity of MELD score combining PCT was 100%, and the positive prediction value was 1.00.

CONCLUSION

Endotoxin and common inflammatory markers (WBC, PMN, and CRP) are not reliable indicators to predict the prognosis in patients with chronic-severe hepatitis. MELD score is significantly correlated with the outcome of mid-term chronic severe hepatitis, PCT and age are both positively correlated with the MELD score. PCT and age combining MELD score can be used to predict the 3 month mid-term mortality of chronic severe hepatitis. MELD score has better prognostic value than PCT. MELD score combining PCT can improve the specificity of prediction.

摘要

目的

评估降钙素原(PCT)、内毒素及常见炎症标志物联合终末期肝病模型(MELD)评分对慢性重型肝炎患者的中期预后价值。

方法

选取2011年5月至2011年12月在中南大学湘雅医院感染科住院的124例慢性重型肝炎患者。入院后24小时内测定炎症指标、肝肾功能及MELD评分,并采集血样检测内毒素、降钙素原(PCT)及C反应蛋白(CRP)。在第3个月末出院随访后确定结局。根据结局将124例患者分为生存组(n = 58)和死亡组(n = 66)。

结果

1)124例患者中,66例死亡,58例存活,单因素分析显示两组在年龄、MELD评分、白细胞(WBC)、中性粒细胞(PMN)、CRP及PCT方面存在统计学差异(P < 0.05)。二元logistic回归分析表明年龄、MELD评分及PCT与结局高度相关(OR分别为1.07、1.42和1.02,P < 0.05),可用于预测慢性重型肝炎3个月的中期死亡率。2)MELD评分与中期死亡率显著相关。年龄与MELD评分呈正相关,Pearson相关系数为0.21(P < 0.05)。PCT也与MELD呈正相关,Spearman相关系数为0.54(P < 0.01)。3)根据受试者工作特征(ROC)曲线分析,MELD评分和PCT的曲线下面积(AUC)分别为0.91和0.77,高于其他指标(P < 0.01)。当MELD评分达到30.09及以上时,这些受试患者的预测死亡风险最高(82.26%)。PCT联合MELD评分预测的死亡风险低于单独使用MELD评分(75.00%),但MELD评分联合PCT的特异性为100%,阳性预测值为1.00。

结论

内毒素及常见炎症标志物(WBC、PMN和CRP)不是预测慢性重型肝炎患者预后的可靠指标。MELD评分与慢性重型肝炎中期结局显著相关,PCT和年龄均与MELD评分呈正相关。PCT和年龄联合MELD评分可用于预测慢性重型肝炎3个月的中期死亡率。MELD评分比PCT具有更好的预后价值。MELD评分联合PCT可提高预测的特异性。

相似文献

1
[Prognostic value of procalcitonin, endotoxin and common inflammatory markers combining MELD score in patients with chronic severe hepatitis].[降钙素原、内毒素及常见炎症标志物联合终末期肝病模型评分在慢性重型肝炎患者中的预后价值]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Apr;38(4):388-94. doi: 10.3969/j.issn.1672-7347.2013.04.009.
2
[The diagnostic value of different pro-inflammatory factor in early diagnosis of sepsis in patients with bloodstream infection].[不同促炎因子在血流感染患者脓毒症早期诊断中的诊断价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 Mar;26(3):165-70. doi: 10.3760/cma.j.issn.2095-4352.2014.03.008.
3
[Diagnostic and prognostic value of procalcitonin and common inflammatory markers combining SOFA score in patients with sepsis in early stage].[降钙素原及常见炎症标志物联合序贯器官衰竭评估(SOFA)评分在脓毒症早期患者中的诊断及预后价值]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008 Jan;20(1):23-8.
4
[Significance of serum procalcitonin levels in the evaluation of severity and prognosis of patients with systemic inflammatory response syndrome].[血清降钙素原水平在评估全身炎症反应综合征患者严重程度及预后中的意义]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012 May;24(5):294-7.
5
[Analysis of correlation between inflammatory parameters and severity of sepsis caused by bacterial bloodstream infection in septic patients].[脓毒症患者细菌性血流感染所致脓毒症炎症参数与严重程度的相关性分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Jun;27(6):448-53. doi: 10.3760/cma.j.issn.2095-4352.2015.06.007.
6
Adding C-reactive protein and procalcitonin to the model of end-stage liver disease score improves mortality prediction in patients with complications of cirrhosis.将 C 反应蛋白和降钙素原添加到终末期肝病模型评分中可提高肝硬化并发症患者的死亡率预测。
J Gastroenterol Hepatol. 2018 Mar;33(3):726-732. doi: 10.1111/jgh.13928.
7
[Value of procalcitonin on predicting the severity and prognosis in patients with early ARDS: a prospective observation study].[降钙素原对早期急性呼吸窘迫综合征患者严重程度及预后的预测价值:一项前瞻性观察研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017 Jan;29(1):34-38. doi: 10.3760/cma.j.issn.2095-4352.2017.01.008.
8
[Value of procalcitonin in the early diagnosis of sepsis in Department of Emergency].[降钙素原在急诊科脓毒症早期诊断中的价值]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012 May;24(5):298-301.
9
[The predictor value of peripheral blood procalcitonin levels in the evaluation of prognosis of patients with septic shock].[外周血降钙素原水平在脓毒性休克患者预后评估中的预测价值]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012 Aug;24(8):470-3.
10
Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.降钙素原可预测所有CRB-65分级中社区获得性肺炎死亡低风险患者。
Eur Respir J. 2008 Feb;31(2):349-55. doi: 10.1183/09031936.00054507. Epub 2007 Oct 24.

引用本文的文献

1
Anticipating postoperative complications in hepatobiliary surgery: procalcitonine as predictive factor.预测肝胆外科术后并发症:降钙素原作为预测因子
Front Surg. 2025 Jun 4;12:1564843. doi: 10.3389/fsurg.2025.1564843. eCollection 2025.
2
Procalcitonin and Liver Disease: A Literature Review.降钙素原与肝脏疾病:文献综述
J Clin Transl Hepatol. 2019 Mar 28;7(1):51-55. doi: 10.14218/JCTH.2018.00012. Epub 2018 Nov 23.